Human immunodeficiency virus type 1 recombination: rate, fidelity, and putative hot spots.

PubWeight™: 2.50‹?› | Rank: Top 2%

🔗 View Article (PMC 136766)

Published in J Virol on November 01, 2002

Authors

Jianling Zhuang1, Amanda E Jetzt, Guoli Sun, Hong Yu, George Klarmann, Yacov Ron, Bradley D Preston, Joseph P Dougherty

Author Affiliations

1: Department of Molecular Genetics and Microbiology, Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, USA.

Articles citing this

Estimating the rate of intersubtype recombination in early HIV-1 group M strains. J Virol (2012) 12.78

Dynamics of HIV-1 recombination in its natural target cells. Proc Natl Acad Sci U S A (2004) 4.37

HIV-1 neutralizing antibodies: understanding nature's pathways. Immunol Rev (2013) 3.30

Pervasive genomic recombination of HIV-1 in vivo. Genetics (2004) 2.79

High rates of human immunodeficiency virus type 1 recombination: near-random segregation of markers one kilobase apart in one round of viral replication. J Virol (2003) 2.04

The remarkable frequency of human immunodeficiency virus type 1 genetic recombination. Microbiol Mol Biol Rev (2009) 2.02

Recombination rate and selection strength in HIV intra-patient evolution. PLoS Comput Biol (2010) 1.73

Identification of a major restriction in HIV-1 intersubtype recombination. Proc Natl Acad Sci U S A (2005) 1.71

The role of recombination in the emergence of a complex and dynamic HIV epidemic. Retrovirology (2010) 1.69

Extensive recombination among human immunodeficiency virus type 1 quasispecies makes an important contribution to viral diversity in individual patients. J Virol (2006) 1.68

Nature, position, and frequency of mutations made in a single cycle of HIV-1 replication. J Virol (2010) 1.65

Antiretroviral drug resistance mutations in human immunodeficiency virus type 1 reverse transcriptase increase template-switching frequency. J Virol (2004) 1.59

Genetic recombination of human immunodeficiency virus type 1 in one round of viral replication: effects of genetic distance, target cells, accessory genes, and lack of high negative interference in crossover events. J Virol (2005) 1.57

Contribution of recombination to the evolution of human immunodeficiency viruses expressing resistance to antiretroviral treatment. J Virol (2007) 1.50

Source identification in two criminal cases using phylogenetic analysis of HIV-1 DNA sequences. Proc Natl Acad Sci U S A (2010) 1.49

Extensive intrasubtype recombination in South African human immunodeficiency virus type 1 subtype C infections. J Virol (2007) 1.37

Phylogenetic analysis of population-based and deep sequencing data to identify coevolving sites in the nef gene of HIV-1. Mol Biol Evol (2009) 1.37

HIV-1 reverse transcription. Cold Spring Harb Perspect Med (2012) 1.29

Population genetic estimation of the loss of genetic diversity during horizontal transmission of HIV-1. BMC Evol Biol (2006) 1.27

Mechanism of reduction in titers from lentivirus vectors carrying large inserts in the 3'LTR. Mol Ther (2009) 1.22

Evolution of the human immunodeficiency virus envelope gene is dominated by purifying selection. Genetics (2006) 1.20

Intracellular nucleotide levels and the control of retroviral infections. Virology (2012) 1.19

Recombination every day: abundant recombination in a virus during a single multi-cellular host infection. PLoS Biol (2005) 1.19

HIV recombination: what is the impact on antiretroviral therapy? J R Soc Interface (2005) 1.18

Influence of random genetic drift on human immunodeficiency virus type 1 env evolution during chronic infection. Genetics (2004) 1.16

HIV-1 Genetic Variability and Clinical Implications. ISRN Microbiol (2013) 1.10

Extensive HIV-1 intra-host recombination is common in tissues with abnormal histopathology. PLoS One (2009) 1.08

High rate of genetic recombination in murine leukemia virus: implications for influencing proviral ploidy. J Virol (2006) 1.08

The 3' region of the chicken hypersensitive site-4 insulator has properties similar to its core and is required for full insulator activity. PLoS One (2009) 1.07

An exploratory algorithm to identify intra-host recombinant viral sequences. Mol Phylogenet Evol (2008) 1.07

Current perspectives on HIV-1 antiretroviral drug resistance. Viruses (2014) 1.04

In-depth, longitudinal analysis of viral quasispecies from an individual triply infected with late-stage human immunodeficiency virus type 1, using a multiple PCR primer approach. J Virol (2005) 1.03

Influence of sequence identity and unique breakpoints on the frequency of intersubtype HIV-1 recombination. Retrovirology (2006) 1.03

Sequence determinants of breakpoint location during HIV-1 intersubtype recombination. Nucleic Acids Res (2006) 1.02

Mechanisms and factors that influence high frequency retroviral recombination. Viruses (2011) 1.02

Evolution and recombination of genes encoding HIV-1 drug resistance and tropism during antiretroviral therapy. Virology (2010) 1.02

Genetic recombination between human immunodeficiency virus type 1 (HIV-1) and HIV-2, two distinct human lentiviruses. J Virol (2007) 1.00

Antigenicity and Immunogenicity in HIV-1 Antibody-Based Vaccine Design. J AIDS Clin Res (2012) 1.00

Mapping of positive selection sites in the HIV-1 genome in the context of RNA and protein structural constraints. Retrovirology (2011) 1.00

Comparison of the genetic recombination rates of human immunodeficiency virus type 1 in macrophages and T cells. J Virol (2005) 0.98

Distinguishing functional amino acid covariation from background linkage disequilibrium in HIV protease and reverse transcriptase. PLoS One (2007) 0.95

Frequent intrapatient recombination between human immunodeficiency virus type 1 R5 and X4 envelopes: implications for coreceptor switch. J Virol (2007) 0.95

Pausing during reverse transcription increases the rate of retroviral recombination. J Virol (2006) 0.94

Identifying recombination hot spots in the HIV-1 genome. J Virol (2013) 0.93

Estimating selection pressures on HIV-1 using phylogenetic likelihood models. Stat Med (2008) 0.92

U3 region in the HIV-1 genome adopts a G-quadruplex structure in its RNA and DNA sequence. Biochemistry (2014) 0.92

Accuracy estimation of foamy virus genome copying. Retrovirology (2009) 0.92

Fifteen to twenty percent of HIV substitution mutations are associated with recombination. J Virol (2014) 0.91

HIV gp120 H375 is unique to HIV-1 subtype CRF01_AE and confers strong resistance to the entry inhibitor BMS-599793, a candidate microbicide drug. Antimicrob Agents Chemother (2012) 0.91

Accurately measuring recombination between closely related HIV-1 genomes. PLoS Comput Biol (2010) 0.90

The Libyan HIV Outbreak How do we find the truth? Libyan J Med (2007) 0.90

Most HIV type 1 non-B infections in the Spanish cohort of antiretroviral treatment-naïve HIV-infected patients (CoRIS) are due to recombinant viruses. J Clin Microbiol (2011) 0.90

Selection dramatically reduces effective population size in HIV-1 infection. BMC Evol Biol (2008) 0.89

Evolution of foamy viruses: the most ancient of all retroviruses. Viruses (2013) 0.89

Longitudinal quasispecies analysis of viral variants in HIV type 1 dually infected individuals highlights the importance of sequence identity in viral recombination. AIDS Res Hum Retroviruses (2010) 0.89

Pseudodiploid genome organization AIDS full-length human immunodeficiency virus type 1 DNA synthesis. J Virol (2007) 0.89

Defective virus drives human immunodeficiency virus infection, persistence, and pathogenesis. Clin Vaccine Immunol (2006) 0.89

Mechanism analysis indicates that recombination events in HIV-1 initiate and complete over short distances, explaining why recombination frequencies are similar in different sections of the genome. J Mol Biol (2009) 0.88

Homologous crossovers among molecules of brome mosaic bromovirus RNA1 or RNA2 segments in vivo. J Virol (2005) 0.88

Long-range recombination gradient between HIV-1 subtypes B and C variants caused by sequence differences in the dimerization initiation signal region. J Mol Biol (2008) 0.87

HIV-1 quasispecies delineation by tag linkage deep sequencing. PLoS One (2014) 0.86

The intra-host evolutionary and population dynamics of human immunodeficiency virus type 1: a phylogenetic perspective. Infect Dis Rep (2013) 0.86

A transcriptionally active subgenomic promoter supports homologous crossovers in a plus-strand RNA virus. J Virol (2003) 0.86

Running loose or getting lost: how HIV-1 counters and capitalizes on APOBEC3-induced mutagenesis through its Vif protein. Viruses (2012) 0.85

Frequent associations between CTL and T-Helper epitopes in HIV-1 genomes and implications for multi-epitope vaccine designs. BMC Microbiol (2010) 0.84

Coestimation of recombination, substitution and molecular adaptation rates by approximate Bayesian computation. Heredity (Edinb) (2013) 0.84

Models of RNA virus evolution and their roles in vaccine design. Immunome Res (2010) 0.83

New findings in cleavage sites variability across groups, subtypes and recombinants of human immunodeficiency virus type 1. PLoS One (2014) 0.83

Suboptimal provirus expression explains apparent nonrandom cell coinfection with HIV-1. J Virol (2012) 0.82

Viral sequence analysis from HIV-infected mothers and infants: molecular evolution, diversity, and risk factors for mother-to-child transmission. Clin Perinatol (2010) 0.82

Discovery of novel targets for multi-epitope vaccines: screening of HIV-1 genomes using association rule mining. Retrovirology (2009) 0.81

HIV classification using the coalescent theory. Bioinformatics (2010) 0.81

Recombination Enhances HIV-1 Envelope Diversity by Facilitating the Survival of Latent Genomic Fragments in the Plasma Virus Population. PLoS Comput Biol (2015) 0.81

Computer programs and methodologies for the simulation of DNA sequence data with recombination. Front Genet (2013) 0.81

Effects of identity minimization on Moloney murine leukemia virus template recognition and frequent tertiary template-directed insertions during nonhomologous recombination. J Virol (2007) 0.80

Patterns of recombination in HIV-1M are influenced by selection disfavouring the survival of recombinants with disrupted genomic RNA and protein structures. PLoS One (2014) 0.80

The Effect of Interference on the CD8(+) T Cell Escape Rates in HIV. Front Immunol (2015) 0.79

Feline immunodeficiency virus (FIV) env recombinants are common in natural infections. Retrovirology (2014) 0.79

Optimal timing and duration of induction therapy for HIV-1 infection. PLoS Comput Biol (2007) 0.79

Gene therapy targeting HIV entry. Viruses (2014) 0.79

Mechanism of HIV-1 RNA dimerization in the central region of the genome and significance for viral evolution. J Biol Chem (2013) 0.78

HIV-1 Transmission, Replication Fitness and Disease Progression. Virology (Auckl) (2008) 0.78

Model-based inference of recombination hotspots in a highly variable oncogene [corrected]. J Mol Evol (2004) 0.77

Proviral progeny of heterodimeric virions reveal a high crossover rate for human immunodeficiency virus type 2. J Virol (2006) 0.77

The key role for local base order in the generation of multiple forms of China HIV-1 B'/C intersubtype recombinants. BMC Evol Biol (2005) 0.77

Retroviral vectors for analysis of viral mutagenesis and recombination. Viruses (2014) 0.76

Investigating the Consequences of Interference between Multiple CD8+ T Cell Escape Mutations in Early HIV Infection. PLoS Comput Biol (2016) 0.76

Paucity of Intact Non-Induced Provirus with Early, Long-Term Antiretroviral Therapy of Perinatal HIV Infection. PLoS One (2017) 0.75

Resolution of Specific Nucleotide Mismatches by Wild-Type and AZT-Resistant Reverse Transcriptases during HIV-1 Replication. J Mol Biol (2016) 0.75

Analysis of HIV-1 intersubtype recombination breakpoints suggests region with high pairing probability may be a more fundamental factor than sequence similarity affecting HIV-1 recombination. Virol J (2016) 0.75

HIV-infected sex workers with beneficial HLA-variants are potential hubs for selection of HIV-1 recombinants that may affect disease progression. Sci Rep (2015) 0.75

HIV-1 Mutation and Recombination Rates Are Different in Macrophages and T-cells. Viruses (2016) 0.75

Buffering deleterious polymorphisms in highly constrained parts of HIV-1 envelope by flexible regions. Retrovirology (2016) 0.75

Articles cited by this

Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol (1986) 37.70

Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol (1995) 9.02

The accuracy of reverse transcriptase from HIV-1. Science (1988) 8.24

Fidelity of HIV-1 reverse transcriptase. Science (1988) 8.08

Structure, replication, and recombination of retrovirus genomes: some unifying hypotheses. J Gen Virol (1979) 7.69

Retroviral recombination and reverse transcription. Science (1990) 6.27

Construction and use of a safe and efficient amphotropic packaging cell line. Virology (1988) 5.58

Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity. J Virol (1990) 5.01

Genetic recombination with avian tumor virus. Virology (1972) 4.23

Retrovirus variation and reverse transcription: abnormal strand transfers result in retrovirus genetic variation. Proc Natl Acad Sci U S A (1993) 4.04

Recombination in AIDS viruses. J Mol Evol (1995) 3.94

The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. J Virol (1996) 3.82

Mechanism of DNA strand transfer reactions catalyzed by HIV-1 reverse transcriptase. Science (1992) 3.81

Specificity and mechanism of error-prone replication by human immunodeficiency virus-1 reverse transcriptase. J Biol Chem (1989) 3.80

Genetic recombination of human immunodeficiency virus. J Virol (1989) 3.61

Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission. J Virol (1996) 3.48

High rate of recombination throughout the human immunodeficiency virus type 1 genome. J Virol (2000) 3.09

Genetically stable reassortment of markers during mixed infection with avian tumor viruses. Virology (1971) 3.05

Fidelity of two retroviral reverse transcriptases during DNA-dependent DNA synthesis in vitro. Mol Cell Biol (1989) 3.00

Determination of the rate of base-pair substitution and insertion mutations in retrovirus replication. J Virol (1988) 2.88

Mutant human immunodeficiency virus type 1 genomes with defects in RNA dimerization or encapsidation. J Virol (1997) 2.86

Reverse transcriptases and genomic variability: the accuracy of DNA replication is enzyme specific and sequence dependent. EMBO J (1990) 2.64

Requirements for kissing-loop-mediated dimerization of human immunodeficiency virus RNA. J Virol (1996) 2.53

Understanding the genetic diversity of HIV-1. AIDS (2000) 2.39

Fidelity of HIV-1 reverse transcriptase copying RNA in vitro. Biochemistry (1992) 2.27

Marked infidelity of human immunodeficiency virus type 1 reverse transcriptase at RNA and DNA template ends. Proc Natl Acad Sci U S A (1994) 2.12

HIV-1 sequence variation: drift, shift, and attenuation. Cell (2001) 2.10

Genetic diversity of HIV-1: the moving target. AIDS (2000) 2.08

On the fidelity of DNA replication. Lack of exodeoxyribonuclease activity and error-correcting function in avian myeloblastosis virus DNA polymerase. J Biol Chem (1976) 2.06

Genetic recombination among temperature-sensitive mutnats of Rous sarcoma virus. Cold Spring Harb Symp Quant Biol (1975) 1.86

A molecular clone of HIV-1 tropic and cytopathic for human and chimpanzee lymphocytes. Virology (1993) 1.83

Origins and evolution of AIDS viruses. Biol Bull (1999) 1.77

Strand transfer mediated by human immunodeficiency virus reverse transcriptase in vitro is promoted by pausing and results in misincorporation. J Biol Chem (1995) 1.68

Genetic rearrangements occurring during a single cycle of murine leukemia virus vector replication: characterization and implications. J Virol (1995) 1.62

Fidelity of human immunodeficiency virus type I reverse transcriptase in copying natural DNA. Nucleic Acids Res (1989) 1.61

Homologous recombination occurs in a distinct retroviral subpopulation and exhibits high negative interference. J Virol (1997) 1.57

Subtype G and multiple forms of A/G intersubtype recombinant human immunodeficiency virus type 1 in Nigeria. Virology (1999) 1.54

Determination of the site of first strand transfer during Moloney murine leukemia virus reverse transcription and identification of strand transfer-associated reverse transcriptase errors. EMBO J (1997) 1.54

The nature of human immunodeficiency virus type 1 strand transfers. J Biol Chem (1998) 1.52

HIV-1 genetic subtype A/B recombinant strain causing an explosive epidemic in injecting drug users in Kaliningrad. AIDS (1998) 1.50

Inducible human immunodeficiency virus type 1 packaging cell lines. J Virol (1996) 1.49

Genetic studies of temperature-sensitive mutants of Moloney-murine leukemia virus. Virology (1973) 1.35

The kissing hairpin sequence promotes recombination within the HIV-I 5' leader region. J Biol Chem (2001) 1.24

Correlated template-switching events during minus-strand DNA synthesis: a mechanism for high negative interference during retroviral recombination. J Virol (1998) 1.21

High rate of genetic rearrangement during replication of a Moloney murine leukemia virus-based vector. J Virol (1993) 1.21

The HIV-1 repeated sequence R as a robust hot-spot for copy-choice recombination. Nucleic Acids Res (2001) 1.15

Mutational analysis of HIV-1 long terminal repeats to explore the relative contribution of reverse transcriptase and RNA polymerase II to viral mutagenesis. J Biol Chem (2002) 1.09

A new human immunodeficiency virus type 1 circulating recombinant form from Tanzania. AIDS Res Hum Retroviruses (2001) 1.04

Fidelity of in vitro DNA strand transfer reactions catalyzed by HIV-1 reverse transcriptase. Biochemistry (1994) 1.02

Misincorporation by HIV-1 reverse transcriptase promotes recombination via strand transfer synthesis. J Biol Chem (1996) 0.91

An outbreak of the circulating recombinant form AECM240 HIV-1 in the Finnish injection drug user population. AIDS (2000) 0.88

Reverse transcription of the yeast Ty1 retrotransposon: the mode of first strand transfer is either intermolecular or intramolecular. J Mol Biol (1999) 0.86

Molecular analysis of the full-length genome of HIV type 1 subtype I: evidence of A/G/I recombination. AIDS Res Hum Retroviruses (1999) 0.86

The identification of a complex A/G/I/J recombinant HIV type 1 virus in various West African countries. AIDS Res Hum Retroviruses (1999) 0.84

Strand transfer is enhanced by mismatched nucleotides at the 3' primer terminus: a possible link between HIV reverse transcriptase fidelity and recombination. Nucleic Acids Res (1996) 0.84

Evidence of the existence of a new circulating recombinant form of HIV type 1 subtype A/J in Cameroon. The European Network on the Study of In Utero Transmission of HIV-1. AIDS Res Hum Retroviruses (2000) 0.84

Articles by these authors

The Genomes of Oryza sativa: a history of duplications. PLoS Biol (2005) 7.67

Global histone modification patterns predict risk of prostate cancer recurrence. Nature (2005) 7.03

A draft sequence for the genome of the domesticated silkworm (Bombyx mori). Science (2004) 6.62

Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell (2011) 5.63

PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex. J Biol Chem (2007) 4.79

GeneWays: a system for extracting, analyzing, visualizing, and integrating molecular pathway data. J Biomed Inform (2004) 4.57

Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases. Proc Natl Acad Sci U S A (2007) 4.20

Frontiers of biomedical text mining: current progress. Brief Bioinform (2007) 4.11

Neither agouti-related protein nor neuropeptide Y is critically required for the regulation of energy homeostasis in mice. Mol Cell Biol (2002) 3.14

Hid, Rpr and Grim negatively regulate DIAP1 levels through distinct mechanisms. Nat Cell Biol (2002) 2.95

Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T cells. Science (2009) 2.76

DNA polymerase epsilon and delta proofreading suppress discrete mutator and cancer phenotypes in mice. Proc Natl Acad Sci U S A (2009) 2.57

Prognostic relevance of the mTOR pathway in renal cell carcinoma: implications for molecular patient selection for targeted therapy. Cancer (2007) 2.38

Global levels of histone modifications predict prognosis in different cancers. Am J Pathol (2009) 2.28

Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism. Proc Natl Acad Sci U S A (2002) 2.00

High incidence of epithelial cancers in mice deficient for DNA polymerase delta proofreading. Proc Natl Acad Sci U S A (2002) 1.95

Mutator phenotypes caused by substitution at a conserved motif A residue in eukaryotic DNA polymerase delta. J Biol Chem (2005) 1.94

Mouse model for human arginase deficiency. Mol Cell Biol (2002) 1.88

Mitochondrial 12S rRNA variants in 1642 Han Chinese pediatric subjects with aminoglycoside-induced and nonsyndromic hearing loss. Mitochondrion (2010) 1.80

A newly discovered function for RNase L in regulating translation termination. Nat Struct Mol Biol (2005) 1.80

Mutation at the polymerase active site of mouse DNA polymerase delta increases genomic instability and accelerates tumorigenesis. Mol Cell Biol (2007) 1.74

Automatically classifying sentences in full-text biomedical articles into Introduction, Methods, Results and Discussion. Bioinformatics (2009) 1.74

Down-regulation of miR-141 in gastric cancer and its involvement in cell growth. J Gastroenterol (2009) 1.73

Arginases I and II: do their functions overlap? Mol Genet Metab (2004) 1.67

Short communication: activation of latent HIV type 1 gene expression by suberoylanilide hydroxamic acid (SAHA), an HDAC inhibitor approved for use to treat cutaneous T cell lymphoma. AIDS Res Hum Retroviruses (2009) 1.66

New transmembrane AMPA receptor regulatory protein isoform, gamma-7, differentially regulates AMPA receptors. J Neurosci (2007) 1.62

Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma. Clin Cancer Res (2007) 1.61

Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma. J Urol (2005) 1.60

AskHERMES: An online question answering system for complex clinical questions. J Biomed Inform (2011) 1.57

Multiple apoptotic caspase cascades are required in nonapoptotic roles for Drosophila spermatid individualization. PLoS Biol (2003) 1.57

Regulation of mitochondrial oxidative phosphorylation through cell signaling. Biochim Biophys Acta (2007) 1.51

Using protein expressions to predict survival in clear cell renal carcinoma. Clin Cancer Res (2004) 1.51

Alternative mechanisms by which mediator subunit MED1/TRAP220 regulates peroxisome proliferator-activated receptor gamma-stimulated adipogenesis and target gene expression. Mol Cell Biol (2007) 1.50

Global analysis of Pub1p targets reveals a coordinate control of gene expression through modulation of binding and stability. Mol Cell Biol (2005) 1.50

Lancet: a high precision medication event extraction system for clinical text. J Am Med Inform Assoc (2010) 1.49

Human dermal stem cells differentiate into functional epidermal melanocytes. J Cell Sci (2010) 1.48

Complete genome sequence of bacteriophage T5. Virology (2005) 1.48

Molecular architecture and ligand recognition determinants for T4 RNA ligase. J Biol Chem (2005) 1.47

Hippocampal AMPA receptor gating controlled by both TARP and cornichon proteins. Neuron (2010) 1.45

Effect of antisense VEGF cDNA transfection on the growth of chronic myeloid leukemia K562 cells in vitro and in nude mice. Leuk Res (2004) 1.45

Role of individual basal ganglia nuclei in force amplitude generation. J Neurophysiol (2007) 1.44

Neuromodulation of the cingulum for neuropathic pain after spinal cord injury. Case report. J Neurosurg (2007) 1.42

Heat stress-induced response of the proteomes of leaves from Salvia splendens Vista and King. Proteome Sci (2013) 1.41

Association of genetic polymorphisms in the fibrinogen and platelet glycoprotein genes with unstable angina in Chinese patients. Clin Cardiol (2004) 1.39

TARPs differentially decorate AMPA receptors to specify neuropharmacology. Trends Neurosci (2010) 1.39

FigSum: automatically generating structured text summaries for figures in biomedical literature. AMIA Annu Symp Proc (2009) 1.38

A role for the melanocortin 4 receptor in sexual function. Proc Natl Acad Sci U S A (2002) 1.38

Parameter uncertainty analysis of non-point source pollution from different land use types. Sci Total Environ (2009) 1.37

Mutant V600E BRAF increases hypoxia inducible factor-1alpha expression in melanoma. Cancer Res (2007) 1.37

Statin and stromal cell-derived factor-1 additively promote angiogenesis by enhancement of progenitor cells incorporation into new vessels. Stem Cells (2008) 1.34

Hierarchical modularity of nested bow-ties in metabolic networks. BMC Bioinformatics (2006) 1.33

Immunoproteomic discovery of novel T cell antigens from the obligate intracellular pathogen Chlamydia. J Immunol (2008) 1.32

TNF/TNFR signal transduction pathway-mediated anti-apoptosis and anti-inflammatory effects of sodium ferulate on IL-1β-induced rat osteoarthritis chondrocytes in vitro. Arthritis Res Ther (2012) 1.30

Interleukin 6 underlies angiotensin II-induced hypertension and chronic renal damage. Hypertension (2011) 1.29

High frequency deep brain stimulation attenuates subthalamic and cortical rhythms in Parkinson's disease. Front Hum Neurosci (2012) 1.29

Exploring supervised and unsupervised methods to detect topics in biomedical text. BMC Bioinformatics (2006) 1.28

Biomedical negation scope detection with conditional random fields. J Am Med Inform Assoc (2010) 1.27

Age-related molecular genetic changes of murine bone marrow mesenchymal stem cells. BMC Genomics (2010) 1.27

The human immunodeficiency virus type 1 ribosomal frameshifting site is an invariant sequence determinant and an important target for antiviral therapy. J Virol (2004) 1.27

Region of interest template for the human basal ganglia: comparing EPI and standardized space approaches. Neuroimage (2007) 1.26

Migration of mesenchymal stem cells to heart allografts during chronic rejection. Transplantation (2003) 1.26

Lethal mutagenesis of HIV. Virus Res (2005) 1.26

Efficacy of pulmonary vein isolation by cryoballoon ablation in patients with paroxysmal atrial fibrillation. Heart Rhythm (2008) 1.26

Modular co-evolution of metabolic networks. BMC Bioinformatics (2007) 1.23

Expression of X-linked inhibitor of apoptosis protein is a strong predictor of human prostate cancer recurrence. Clin Cancer Res (2007) 1.23

Hypophosphorylation of residue Y1045 leads to defective downregulation of EGFRvIII. Cancer Biol Ther (2006) 1.20

Melanin-concentrating hormone receptor subtypes 1 and 2: species-specific gene expression. Genomics (2002) 1.20

Clinical study of laparoscopic versus open hepatectomy for malignant liver tumors. Surg Endosc (2008) 1.20

Defects in homologous recombination repair in mismatch-repair-deficient tumour cell lines. Hum Mol Genet (2002) 1.19

C-Myc-activated long noncoding RNA CCAT1 promotes colon cancer cell proliferation and invasion. Tumour Biol (2014) 1.19

The serine/threonine kinase dPak is required for polarized assembly of F-actin bundles and apical-basal polarity in the Drosophila follicular epithelium. Dev Biol (2007) 1.18

Interactions between extracellular signal-regulated kinase 1/2 and p38 MAP kinase pathways in the control of RUNX2 phosphorylation and transcriptional activity. J Bone Miner Res (2012) 1.18

Incorporation of uracil into minus strand DNA affects the specificity of plus strand synthesis initiation during lentiviral reverse transcription. J Biol Chem (2002) 1.16

A pathway-dependent on apoE, ApoAI, and ABCA1 determines formation of buoyant high-density lipoprotein by macrophage foam cells. Arterioscler Thromb Vasc Biol (2007) 1.15

Laparoscopic liver resection and the learning curve: a 14-year, single-center experience. Surg Endosc (2014) 1.15

Stromal cell-derived factor-1 enhances pro-angiogenic effect of granulocyte-colony stimulating factor. Cardiovasc Res (2006) 1.15

Availability and quality of paraffin blocks identified in pathology archives: a multi-institutional study by the Shared Pathology Informatics Network (SPIN). BMC Cancer (2007) 1.14

Role of the basal ganglia and frontal cortex in selecting and producing internally guided force pulses. Neuroimage (2007) 1.14

Effect of hepatocyte apoptosis induced by TNF-alpha on acute severe hepatitis in mouse models. World J Gastroenterol (2000) 1.14

Mutations in POFUT1, encoding protein O-fucosyltransferase 1, cause generalized Dowling-Degos disease. Am J Hum Genet (2013) 1.13

Regulation of energy homeostasis by bombesin receptor subtype-3: selective receptor agonists for the treatment of obesity. Cell Metab (2010) 1.13

Association study of the polymorphisms in the KISS1 gene with central precocious puberty in Chinese girls. Eur J Endocrinol (2007) 1.13

Small-molecule activation of the TRAIL receptor DR5 in human cancer cells. Nat Chem Biol (2012) 1.13

Decoding cell lineage from acquired mutations using arbitrary deep sequencing. Nat Methods (2011) 1.12

Carbonic anhydrase IX in bladder cancer: a diagnostic, prognostic, and therapeutic molecular marker. Cancer (2009) 1.11

Generation of mouse ES cell lines engineered for the forced induction of transcription factors. Sci Rep (2011) 1.11

Laparoscopic hepatectomy for hepatolithiasis: a feasibility and safety study in 29 patients. Surg Endosc (2007) 1.11

Genome-wide binding analysis of the transcription activator ideal plant architecture1 reveals a complex network regulating rice plant architecture. Plant Cell (2013) 1.10

Regulation of gene expression in experimental autoimmune encephalomyelitis indicates early neuronal dysfunction. Brain (2003) 1.10

Hydrogen peroxide-mediated isoniazid activation catalyzed by Mycobacterium tuberculosis catalase-peroxidase (KatG) and its S315T mutant. Biochemistry (2006) 1.10

Principles and analytical performance of Abbott RealTime High Risk HPV test. J Clin Virol (2009) 1.10

Age-related sensitivity and pathological differences in infections by 2009 pandemic influenza A (H1N1) virus. Virol J (2011) 1.09

CordyMax Cs-4 improves glucose metabolism and increases insulin sensitivity in normal rats. J Altern Complement Med (2002) 1.09

Mutational analysis of HIV-1 long terminal repeats to explore the relative contribution of reverse transcriptase and RNA polymerase II to viral mutagenesis. J Biol Chem (2002) 1.09

Intracranial hypotension producing reversible coma: a systematic review, including three new cases. J Neurosurg (2012) 1.09

Automatically classifying sentences in full-text biomedical articles into introduction, methods, results and discussion. Summit on Translat Bioinforma (2009) 1.08